SEC Comment Letter for New Frontier Health Corp (CIK 0001737422) — Jan 28, 2020
New Frontier Health Corp (CIK 0001737422)
Date: Jan. 28, 2020 · CIK: 0001737422 · Accession: 0000000000-20-000737
AI Filing Summary & Sentiment
File numbers found in text: 333-236079
Letter
January 28, 2020 Roberta Lipson Chief Executive Officer New Frontier Health Corporation 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100015, Beijing, China Re:New Frontier Health Corporation Registration Statement on Form F-1 Filed January 24, 2020 File No. 333-236079 Dear Ms. Lipson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jonathan Burr at 202-551-5833 with any questions. Sincerely, Division of Corporation Finance Office of Real Estate & Construction
Show Raw Text
January 28, 2020
Roberta Lipson
Chief Executive Officer
New Frontier Health Corporation
10 Jiuxianqiao Road,
Hengtong Business Park
B7 Building, 1/F
Chaoyang District, 100015,
Beijing, China
Re:New Frontier Health Corporation
Registration Statement on Form F-1
Filed January 24, 2020
File No. 333-236079
Dear Ms. Lipson:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jonathan Burr at 202-551-5833 with any questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction